复星医药:控股子公司与VerImmune签订独家许可及选择协议
特斯拉“最牛散户”廖凯原(Leo KoGuan):特斯拉应该立即宣布用今年的自由现金流回购50亿美元股票、用明年的自由现金流回购100亿美元股票,这完全不影响其180亿美元现金储备和零债务立场。","multimedia":{"img_url":["https://n.sinaimg.cn/zhibo/109/w601h308/20220519/cff8-4c5b6f5abd939d88c09d46901504f995.png"]},"commentid":"live:finance-152-2676933:0","compere_id":0,"creator":"qiqi7@staff.sina.com.cn","mender":"qiqi7@staff.sina.com.cn","create_time":"2022-05-19 17:00:39","update_time":"2022-05-19 17:01:00","is_need_check":"0","check_time":"1970-01-01 08:00:01","check_status":"1","check_user":"","is_delete":0,"top_value":0,"is_focus":0,"source_content_id":"0","anchor_image_url":"","anchor":"直播员","ext":"{"stocks":[{"market":"us","symbol":"tsla","key":"u7279u65afu62c9"}],"needPush":false,"needAIPush":false,"needCMSLink":true,"needCalender":false,"needProvince":"0","docurl":"https:\/\/finance.sina.com.cn\/7x24\/2022-05-19\/doc-imcwiwst8307417.shtml","docid":"mcwiwst8307417"}","old_live_cid":"0","tag":[{"id":"3","name":"公司"},{"id":"9","name":"焦点"}],"like_nums":0,"comment_list":{"list":[],"total":0,"thread_show":0,"qreply":0,"qreply_show":0,"show":0},"docurl":"https://finance.sina.cn/7x24/2022-05-19/detail-imcwiwst8307417.d.html","rich_text_nick_to_url":[],"rich_text_nick_to_routeUri":[],"compere_info":""},{"id":2676932,"zhibo_id":152,"type":0,"rich_text":" 【复星医药:控股子公司与VerImmune签订独家许可及选择协议】复星医药公告,控股子公司Fosun Pharma USA与VerImmune签订《独家许可及选择协议》,VerImmune授权Fosun Pharma USA使用其专有技术和专利在区域内(即中国大陆及港澳台地区)及领域内(即治疗、缓解、诊断或预防人类或动物疾病)独家临床开发、进口及商业化基于类病毒颗粒的肿瘤免疫药物VERI-101。
本文系网络转载,不代表本站立场。